Skybiotech Healthcare Limited Financial Ratios
SKYBIOTECH · Consumer Discretionary · Current price ₹142.75
P/E ratio
13.4x
P/B ratio
3.3x
ROE
-22.5%
ROCE
-13.8%
Debt / Equity
1.05
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 13.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 3.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -22.5% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -13.8% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.05 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Skybiotech Healthcare Limited's latest numbers.
Skybiotech Healthcare Limited profitability
Skybiotech Healthcare Limited generates a return on equity of -22.5% and a return on capital employed of -13.8%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.05 and a P/E of 13.4x, Skybiotech Healthcare Limited is moderately leveraged. Our overall business-quality score for the company is 3.4 / 10.
Understand the ratios
More on Skybiotech Healthcare Limited
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.